Category
Alfuzosin
CAS Number
1026411-59-5
Molecular Formula
C₁₅H₂₁N₅O₃
Molecular Weight
319.37 g/mol
Synonym

N-(3-((4-amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino)propyl)formamide; Alfuzosin Hydrochloride - Impurity E;

Keywords
Impurities Manufacturer in India
Impurities manufacturer and Suppliers in Hyderabad india
Impurities
Slide_1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Manasa Life Sciences is a trusted manufacturer and supplier of Alfuzosin EP Impurity E (CAS No. 1026411-59-5), a high-quality pharmaceutical analytical reference standard characterized by the molecular formula C₁₅H₂₁N₅O₃, molecular weight 319.36 g/mol, and chemical name Methyl N-[3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)-methylamino]propyl]formamide. Alfuzosin EP Impurity E is intended for impurity profiling, related-substance testing, HPLC method development, analytical method validation, pharmaceutical quality control, and stability studies. The material is characterized using advanced analytical techniques, including HPLC, LC-MS, NMR, and IR spectroscopy, to support identity, purity, and batch consistency. Manufactured under stringent GMP-aligned quality practices and handled through GDP-compliant supply and logistics processes, the product is supplied with essential documentation, including a Certificate of Analysis (CoA) and Safety Data Sheet (SDS/MSDS), supporting pharmaceutical analytical testing and applicable USP, EP, USFDA, EMA, and ICH regulatory requirements.